摘要
近年来,随着高频彩色多普勒超声的广泛应用,超声对甲状腺癌的检出率有所提高。本组通过分析64例甲状腺癌结节患者的超声多普勒检查资料,以探讨其血流动力学变化特征。
出处
《临床超声医学杂志》
2011年第4期277-278,共2页
Journal of Clinical Ultrasound in Medicine
参考文献5
-
1Adler DD,Carson PL,Rubin JM,et al.Doppler ultrasound color flow imaging in the study of breast cancer:preliminary findings.Ultrasound Med Biol,1990,16(6):553-559.
-
2Kang HW,No JH,Chung JH,et al.Prevalence,clinical and ultrasonographic characteristics of thyroid incidentalomas.Thyroid,2004,14(1):29-33.
-
3吴白云,郑宗英,邹利芝.甲状腺癌超声诊断及其误诊分析[J].中国超声医学杂志,1997,13(5):51-53. 被引量:31
-
4赵瑛,王建华,王金锐.甲状腺微小癌超声征象的多元回归分析[J].临床超声医学杂志,2010,12(2):84-87. 被引量:24
-
5Algin O.Spectral power Doppler ultrasound parameters:are they really Significant? Laryngoscope.2009,119(7):1452-1453.
二级参考文献14
-
1李凤华,夏建国,李红丽,吴春华.高性能超声对甲状腺微小癌的诊断价值[J].中国医学影像技术,2004,20(z1):5-7. 被引量:28
-
2华秀云,秦茜淼.甲状腺结节的声像图与临床和病理对照[J].中国超声医学杂志,1993,9(6):405-408. 被引量:49
-
3柳文仪.甲状腺超声诊断现状[J].中国超声医学杂志,1995,11(4):272-273. 被引量:78
-
4詹维伟.浅表淋巴结的超声诊断[J].中国医学影像学杂志,1996,4(1):51-53. 被引量:9
-
5吴春华,李凤华.超声对甲状腺良恶性肿瘤的诊断价值[J].上海医学影像,2006,15(2):109-110. 被引量:7
-
6Baudill E,Travagli JP, Ropers J , et al. Microcarcinoma of the thyroid gland. Cancer, 1998,83 ( 5 ) :553 - 559.
-
7Yoon DY, Lee JW, Chang SK, et,al. Peripheral calcification in thyroid nodules : ultrasonographic features and prediction of malignancy. J Ultrasound Med, 2007,26 ( 10 ) : 1349 - 1355.
-
8Camargo RY, Tomimori EK. Usefulness of ultrasound in the diagnosis and management of well -differentiated thyroid carcinoma. Arq Bras Endocrinol Metabol, 2007,51 ( 5 ) :783 - 792.
-
9Rago T, Di Coscio G, Basolo F, et al. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (Oxf). 2007,66 (1):13-20.
-
10Kwak JY, Kim EK, Kim MJ, et al. Papillary microcarcinoma of the thyroid : predicting factors of lateral neck node metastasis. Ann Surg Oncol, 2009,16(5) :1348 - 1355.
共引文献53
-
1丛娟,秦石成,常建民,栗河舟.甲状腺癌的二维及彩色多普勒超声分析[J].中国超声诊断杂志,2006,7(5):321-323. 被引量:11
-
2李泉水,张家庭,田平,李征毅,粟晖,高露露,杨秋红,李振洲.甲状腺癌的声像图特征研究[J].中国医学影像技术,2006,22(4):554-556. 被引量:48
-
3林喃,黄建康,马玲.二维及彩色多普勒超声对甲状腺癌的诊断价值[J].实用全科医学,2006,4(5):596-597. 被引量:11
-
4皮小兰,李车英,徐翔,李薇,刘燕娜,黄敏,李沿江.甲状腺癌的超声误诊分析[J].江西医学院学报,2007,47(3):81-83. 被引量:3
-
5刘思怡,蔡永秋,吴绍锋.甲状腺癌的二维及彩色多普勒超声诊断[J].中国医药导报,2008,5(20):101-102. 被引量:10
-
6张小洁,吕应莲.甲状腺癌的超声学特点及临床应用——附7例报告[J].医学信息,2008,21(8):1421-1423.
-
7许志辉,熊洁霞,王必莉,秦杰,毕小春.甲状腺癌的弥漫性微小钙化的超声研究[J].中国医学创新,2008,5(30):119-120. 被引量:3
-
8陶宏.二维及彩色多普勒超声对甲状腺癌的诊断价值分析[J].中外医疗,2008,27(28):8-9. 被引量:5
-
9王良玉,温纯全,陈恕,马陈声,李木泉.196例甲状腺疾病的彩色B超诊断与手术病理诊断对照分析[J].实用医学杂志,1998,14(4):254-255.
-
10杨惠詠.弥漫性甲状腺癌的超声诊断与分析[J].中国现代医生,2009,47(23):45-46. 被引量:3
同被引文献25
-
1PEYSSONNAUX C, EYCHENE A. The RAF/MEK/ERK pathway: new concepts of activation[J]. Biol Cell, 2001,93 : 53-62.
-
2ADENIRAN A J, ZHU Z, GANDHI M, et al. Correlation be- tween genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papil- lary carcinomasJ]. Am J Surg Pathol, 2006,30:216-222.
-
3MASAGO K, ASATO R, FUJITA S, et al. Epidermal growth factor receptor mutations in papillary thyroid carcino- ma[J]. Int J Cancer, 2009, 124 :2744-2749.
-
4TAMAS P, SOLTI Z, BAUER P. Mechanism of epidermal growth factor Regulation of Vav2, a guanine nucleotide ex- change factor for Rac [J]. J Biol Chem, 2003,278 (2) : 5163- 5171.
-
5XING M Z. BRAF mutation in thyroid cancer[J]. Endocrine Related Cancer, 2005,12 : 245-262.
-
6JOY S, II S,SONG J H, et al. Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid Cancer[J]. J Clin Endocrinol Metab, 2006, 91:3667-3670.
-
7KIM S K, SONG K H, LIM S D, et al. Clinical and pathologi cal features and the BRAF (V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hash- imoto thyroiditis[J]. Thyroid, 2009,19(2) : 137-141.
-
8XING M Z. BRAF mutation in papillary thyroid cancer: pa thogenic role, molecular bases, and clinical implications[J]. Endocrine Reviews, 2007,28(7) :742-762.
-
9HWANG J, SHIN J H, HAN B K, et al. Papillary thyroid carcinoma with BRAF V600E mutation: sonographic predic- tion[J]. AJR, 2010, 194(5)..W425-W430.
-
10JOY S, LI S, SONG J H, et al. Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer[J]. J Clin Endocrinol Metab, 2006,91 : 3667-3670.
二级引证文献25
-
1左芙蓉.彩色多普勒超声在甲状腺癌诊断中的应用[J].今日健康,2016,15(8):360-360.
-
2黄美玲,李永平,凌瑞.BRAF^(V600E)基因突变与乳头状甲状腺癌淋巴结转移相关性的Meta分析[J].中国肿瘤,2017,26(2):145-151. 被引量:29
-
3高杰.彩色多普勒超声及超声造影对甲状腺癌颈部淋巴结转移的诊断价值[J].中国实用医刊,2017,44(19):26-28. 被引量:14
-
4陈湘光,杨志企,黄翔.多排螺旋CT与彩色多普勒超声在甲状腺癌诊断中的应用价值对比[J].中国实用医药,2018,13(22):44-45. 被引量:5
-
5宋中林.甲状腺腺瘤摘除术不同引流方法的疗效比较[J].现代诊断与治疗,2017,28(15):2880-2881. 被引量:1
-
6熊瑜琦,蒋莉莉,康宁.DWI与多普勒超声及CT对甲状腺癌颈部淋巴结转移癌的临床诊断效果分析[J].实用癌症杂志,2018,33(12):1983-1986. 被引量:27
-
7贾永谦.超声对甲状腺癌和甲状腺腺瘤的诊断与鉴别诊断意义研究[J].现代医用影像学,2018,27(7):2237-2238. 被引量:4
-
8郑良斌.二维及彩色多普勒超声对甲状腺癌的诊断价值探讨[J].基层医学论坛,2019,23(7):972-974. 被引量:8
-
9赵进芳.超声在甲状腺腺瘤中的诊断价值及临床应用探讨[J].实用医学影像杂志,2019,20(1):59-61.
-
10陈荣川.彩色多普勒超声诊断甲状腺肿瘤的临床意义探讨[J].实用医学影像杂志,2019,20(3):291-293. 被引量:1
-
1任瑞芳.甲状腺癌与甲状腺腺瘤的彩超对比分析[J].医学美学美容(中旬刊),2015,24(2):128-128.
-
2潘景升,欧冰,秦威,赵子卓,邓宝雯,马健鸿,王浩虎.常规超声联合超声弹性成像诊断甲状腺癌的价值评估[J].按摩与康复医学,2016,0(15):74-75. 被引量:2
-
3李胜利,吴先盛,鲁树坤,刘明辉,胡建国.肝占位性病变超声多普勒鉴别诊断前瞻性研究[J].湖南医科大学学报,1994,19(1):42-44.
-
4沈友洪,任永富,唐丽娜,闫若元,尚志红,陈静,陈轶洁.甲状腺癌和结节性甲状腺肿的超声鉴别诊断[J].中国医学影像学杂志,2008,16(3):217-219. 被引量:22
-
5王萍.甲状腺微小乳头状癌超声表现对颈部淋巴结转移的预测价值[J].江苏医药,2014,40(21):2599-2600. 被引量:3
-
6周静,龚程.彩色多普勒超声对甲状腺癌的诊断价值[J].上海医学影像,2006,15(4):325-326. 被引量:1
-
7Yaman C,Fridrik M,杨晓梅.妇科恶性肿瘤治疗反应性的三维立体超声评价[J].世界核心医学期刊文摘(妇产科学分册),2005,0(10):35-35. 被引量:2
-
8张强,黄士明,丁季青.腘静脉瘤一例[J].中华外科杂志,2004,42(5):320-320. 被引量:2
-
9邹霞,李泉水,张家庭,粟辉,陈胜华,郭国强,姜健.超声显像鉴别甲状腺癌结节的价值[J].中国医学影像技术,2009,25(10):1777-1780. 被引量:29
-
10郭悦,阮力,何光斌,孙芸.超声多普勒观察肝硬变及弥漫性肝癌肝固有动脉血流动力学改变[J].中国超声医学杂志,1997,13(8):67-68. 被引量:1